Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunodeficiency Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00146328
What this trial is testing

Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects

Who this might be right for
HIV Infections
Boehringer Ingelheim 997
Testing effectiveness (Phase 2)Active Not RecruitingNCT05996471
What this trial is testing

Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

Who this might be right for
HIV Infections
ViiV Healthcare 185
Post-approval studies (Phase 4)Ended earlyNCT02322099
What this trial is testing

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

Who this might be right for
Bone Demineralization
University College Dublin 53
Not applicableStudy completedNCT00000923
What this trial is testing

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 110
Post-approval studies (Phase 4)Looking for participantsNCT07135427
What this trial is testing

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

Who this might be right for
Alpha 1-AntitrypsinCOPDAntibody Deficiency
University of Alabama at Birmingham 30
Not applicableStudy completedNCT03920969
What this trial is testing

Sport and Self Esteem in Patients Living With HIV

Who this might be right for
HIV Seropositivity
Centre Hospitalier le Mans 1,169
Not applicableUnknownNCT04447937
What this trial is testing

Immunodeficiency in MS

Who this might be right for
Multiple SclerosisHypogammaglobulinemiaImmunodeficiency+1 more
Advanced Neurosciences Institute 1,500
Post-approval studies (Phase 4)Study completedNCT00192595
What this trial is testing

Tenofovir in HIV/HBV Coinfection

Who this might be right for
HIV InfectionHepatitis B Coinfection
Kirby Institute 36
Not applicableStudy completedNCT03853681
What this trial is testing

Study on the Response to Tetanus Vaccination of People Living With HIV

Who this might be right for
HIV Infections
Centre Hospitalier de Niort 210
Not applicableStudy completedNCT03678181
What this trial is testing

Increasing Engagement and Improving HIV Outcomes Via HealthMPowerment

Who this might be right for
HIV InfectionsSexually Transmitted DiseasesStigma, Social
University of Pennsylvania 750
Early research (Phase 1)Looking for participantsNCT06513819
What this trial is testing

HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)

Who this might be right for
HivAlcohol DrinkingFall+1 more
Yale University 100
Not applicableStudy completedNCT04880200
What this trial is testing

Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests

Who this might be right for
HIV Infections
University of Washington 194
Large-scale testing (Phase 3)Looking for participantsNCT05813964
What this trial is testing

Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.

Who this might be right for
HIV/AIDS
ANRS, Emerging Infectious Diseases 524
Post-approval studies (Phase 4)Study completedNCT00966329
What this trial is testing

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Who this might be right for
HIVHIV Infections
Germans Trias i Pujol Hospital 30
Early research (Phase 1)UnknownNCT03980665
What this trial is testing

The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART

Who this might be right for
HIV/AIDS
Guangzhou 8th People's Hospital 20
Not applicableActive Not RecruitingNCT07466836
What this trial is testing

The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV

Who this might be right for
Human Immunodeficiency Virus (HIV)
Tyson Perez, DC, PhD 10
Testing effectiveness (Phase 2)Study completedNCT03639311
What this trial is testing

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

Who this might be right for
HIV Infections
ViiV Healthcare 97
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableNot Yet RecruitingNCT07446764
What this trial is testing

Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care

Who this might be right for
HIVSTDs
My Brother's Keeper, Inc. 700
Not applicableStudy completedNCT03250845
What this trial is testing

Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder

Who this might be right for
Hematologic DiseasesSecondary Immune Deficiency
Universitaire Ziekenhuizen KU Leuven 30
Next Page